GGrantIndex
← Leaderboards

Victor L Perez

University Of Miami School Of Medicine

$8,283,705
Attributed
$15,421,718
Total exposure
6
Grants
4
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $2.3M · FY200925
$2.5M$1.9M$1.3M$625K$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$15,421,718 · 6

By mechanism

R01$9,734,723 · 3
U01$5,054,648 · 1
P30$413,655 · 1
R41$218,692 · 1

Top collaborators

Most similar at University Of Miami School Of Medicine

Same institution · by research overlap

Others in their field

Top investigators on “Cells

Research focus

CellsTissuesT-LymphocytePreventImmuneAntigensOrganAllogenicCorneaSurvival RateCytokineMediatingIn VivoInfiltrationProductionInflammatoryHematopoietic Stem Cell TransplantationInterleukin-2Regulatory T-LymphocyteSignal TransductionPathway InteractionsExperimental StudyLabelChimeric Proteins

Grant awards (34)

Blink, Lacrimation, and Nociception: Precision Mapping and Integrated Atlas Generation of Corneal Trigeminal Afferents$1,105,585
U01 · FY2025 · EY
Local regulation and deletion of T cells to induce tolerance and establish long-term survival of high-risk corneal transplants$672,170
R01 · FY2025 · EY
Immune Mechanisms in Ocular Graft versus Host Disease$410,020
R01 · FY2025 · EY · contact PI
Biological Imaging Module$123,371
P30 · FY2025 · EY · contact PI
Blink, Lacrimation, and Nociception: Precision Mapping and Integrated Atlas Generation of Corneal Trigeminal Afferents$1,300,835
U01 · FY2024 · EY
Immune Mechanisms in Ocular Graft versus Host Disease$410,000
R01 · FY2024 · EY · contact PI
Biological Imaging Module$145,142
P30 · FY2024 · EY · contact PI
Blink, Lacrimation, and Nociception: Precision Mapping and Integrated Atlas Generation of Corneal Trigeminal Afferents$1,305,707
U01 · FY2023 · EY
Local regulation and deletion of T cells to induce tolerance and establish long-term survival of high-risk corneal transplants$410,000
R01 · FY2023 · EY
Immune Mechanisms in Ocular Graft versus Host Disease$410,000
R01 · FY2023 · EY · contact PI
Biological Imaging Module$145,142
P30 · FY2023 · EY · contact PI
Local regulation and deletion of T cells to induce tolerance and establish long-term survival of high-risk corneal transplants$68,450
R01 · FY2023 · EY
Blink, Lacrimation, and Nociception: Precision Mapping and Integrated Atlas Generation of Corneal Trigeminal Afferents$1,342,521
U01 · FY2022 · EY
Immune Mechanisms in Ocular Graft versus Host Disease$397,697
R01 · FY2022 · EY · contact PI
Local regulation and deletion of T cells to induce tolerance and establish long-term survival of high-risk corneal transplants$397,393
R01 · FY2022 · EY
Local regulation and deletion of T cells to induce tolerance and establish long-term survival of high-risk corneal transplants$44,785
R01 · FY2022 · EY
Immune Mechanisms in Ocular Graft versus Host Disease$410,000
R01 · FY2021 · EY · contact PI
Local regulation and deletion of T cells to induce tolerance and establish long-term survival of high-risk corneal transplants$397,443
R01 · FY2021 · EY
Local regulation and deletion of T cells to induce tolerance and establish long-term survival of high-risk corneal transplants$410,000
R01 · FY2020 · EY
Immune Mechanisms in Ocular Graft versus Host Disease$450,227
R01 · FY2018 · EY · contact PI
Small Molecule Anti-Inflammatories for Ocular Graft Versus Host Disease$218,692
R41 · FY2018 · EY · contact PI
Immune Mechanisms in Ocular Graft versus Host Disease$575,657
R01 · FY2017 · EY
Immune Mechanisms in Ocular Graft versus Host Disease$682,870
R01 · FY2016 · EY · contact PI
Immune Mechanisms in Ocular Graft versus Host Disease$681,732
R01 · FY2015 · EY · contact PI
Immune Mechanisms in Ocular Graft versus Host Disease$613,998
R01 · FY2014 · EY · contact PI
Immune Mechanisms in Ocular Graft versus Host Disease$94,053
R01 · FY2014 · EY · contact PI
Chemokines and T Cell Recruitment in High Risk Corneal Allograft Rejection$443,213
R01 · FY2013 · EY · contact PI
Chemokines and T Cell Recruitment in High Risk Corneal Allograft Rejection$350,906
R01 · FY2012 · EY · contact PI
Chemokines and T Cell Recruitment in High Risk Corneal Allograft Rejection$88,549
R01 · FY2012 · EY · contact PI
Chemokines and T Cell Recruitment in High Risk Corneal Allograft Rejection$452,684
R01 · FY2011 · EY · contact PI
Chemokines and T Cell Recruitment in High Risk Corneal Allograft Rejection$378,675
R01 · FY2010 · EY · contact PI
Chemokines and T Cell Recruitment in High Risk Corneal Allograft Rejection$38,408
R01 · FY2010 · EY · contact PI
Chemokines and T Cell Recruitment in High Risk Corneal Allograft Rejection$382,500
R01 · FY2009 · EY · contact PI
Chemokines and T Cell Recruitment in High Risk Corneal Allograft Rejection$63,293
R01 · FY2009 · EY · contact PI